Suppr超能文献

ATM介导的hMutL DNA错配修复蛋白的稳定作用在DNA损伤期间增强了p53激活。

ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.

作者信息

Luo Yuhong, Lin Fang-Tsyr, Lin Weei-Chin

机构信息

Department of Medicine, University of Alabama at Birmingham, 35294-3300, USA.

出版信息

Mol Cell Biol. 2004 Jul;24(14):6430-44. doi: 10.1128/MCB.24.14.6430-6444.2004.

Abstract

Human DNA mismatch repair (MMR) proteins correct DNA errors and regulate cellular response to DNA damage by signaling apoptosis. Mutations of MMR genes result in genomic instability and cancer development. Nonetheless, how MMR proteins are regulated has not yet been determined. While hMLH1, hPMS2, and hMLH3 are known to participate in MMR, the function of another member of MutL-related proteins, hPMS1, remains unclear. Here we show that DNA damage induces the accumulation of hPMS1, hPMS2, and hMLH1 through ataxia-telangiectasia-mutated (ATM)-mediated protein stabilization. The subcellular localization of PMS proteins is also regulated during DNA damage, which induces nuclear localization of hPMS1 and hPMS2 in an hMLH1-dependent manner. The induced levels of hMLH1 and hPMS1 are important for the augmentation of p53 phosphorylation by ATM in response to DNA damage. These observations identify hMutL proteins as regulators of p53 response and demonstrate for the first time a function of hMLH1-hPMS1 complex in controlling the DNA damage response.

摘要

人类DNA错配修复(MMR)蛋白可纠正DNA错误,并通过诱导细胞凋亡来调节细胞对DNA损伤的反应。MMR基因的突变会导致基因组不稳定和癌症发生。然而,MMR蛋白是如何被调控的尚未确定。虽然已知hMLH1、hPMS2和hMLH3参与MMR,但MutL相关蛋白的另一个成员hPMS1的功能仍不清楚。在这里,我们表明DNA损伤通过共济失调毛细血管扩张症突变(ATM)介导的蛋白质稳定作用诱导hPMS1、hPMS2和hMLH1的积累。在DNA损伤过程中,PMS蛋白的亚细胞定位也受到调控,这以hMLH1依赖的方式诱导hPMS1和hPMS2的核定位。hMLH1和hPMS1的诱导水平对于ATM在DNA损伤反应中增强p53磷酸化很重要。这些观察结果将hMutL蛋白鉴定为p53反应的调节因子,并首次证明了hMLH1-hPMS1复合物在控制DNA损伤反应中的功能。

相似文献

1
ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.
Mol Cell Biol. 2004 Jul;24(14):6430-44. doi: 10.1128/MCB.24.14.6430-6444.2004.
2
Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells.
J Biol Chem. 2000 May 26;275(21):15728-32. doi: 10.1074/jbc.M908768199.
3
Human MutL-complexes monitor homologous recombination independently of mismatch repair.
DNA Repair (Amst). 2009 Feb 1;8(2):242-52. doi: 10.1016/j.dnarep.2008.10.011. Epub 2008 Nov 29.
4
Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
J Biol Chem. 2010 Oct 22;285(43):33010-33017. doi: 10.1074/jbc.M110.137406. Epub 2010 Aug 6.
6
Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Cancer Chemother Pharmacol. 2002 Jun;49(6):445-52. doi: 10.1007/s00280-002-0450-6. Epub 2002 Apr 20.
7
Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1.
J Biol Chem. 1999 Nov 5;274(45):32368-75. doi: 10.1074/jbc.274.45.32368.
8
Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Am J Hematol. 2005 Feb;78(2):100-7. doi: 10.1002/ajh.20259.
9
DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Biochem Biophys Res Commun. 2001 Jul 13;285(2):409-13. doi: 10.1006/bbrc.2001.5187.

引用本文的文献

2
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation.
Cancer Gene Ther. 2021 Jun;28(6):649-666. doi: 10.1038/s41417-020-00246-9. Epub 2020 Oct 22.
4
Tissue specificity of DNA damage response and tumorigenesis.
Cancer Biol Med. 2019 Aug;16(3):396-414. doi: 10.20892/j.issn.2095-3941.2019.0097.
5
DNA Damage Repair in Huntington's Disease and Other Neurodegenerative Diseases.
Neurotherapeutics. 2019 Oct;16(4):948-956. doi: 10.1007/s13311-019-00768-7.
6
A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer.
Eur Urol. 2019 Feb;75(2):242-250. doi: 10.1016/j.eururo.2018.10.040. Epub 2018 Nov 7.
7
Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods.
Cancer Biol Ther. 2017 Jul 3;18(7):519-533. doi: 10.1080/15384047.2017.1326439. Epub 2017 May 11.
10
p53 in the DNA-Damage-Repair Process.
Cold Spring Harb Perspect Med. 2016 May 2;6(5):a026070. doi: 10.1101/cshperspect.a026070.

本文引用的文献

1
A positive-feedback-based bistable 'memory module' that governs a cell fate decision.
Nature. 2003 Nov 27;426(6965):460-5. doi: 10.1038/nature02089.
3
Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage.
J Biol Chem. 2003 Sep 26;278(39):37782-9. doi: 10.1074/jbc.M304049200. Epub 2003 Jul 11.
6
Chk2 activates E2F-1 in response to DNA damage.
Nat Cell Biol. 2003 May;5(5):401-9. doi: 10.1038/ncb974.
7
Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Mol Cell Biol. 2003 May;23(9):3320-8. doi: 10.1128/MCB.23.9.3320-3328.2003.
8
The Chk2 tumor suppressor is not required for p53 responses in human cancer cells.
J Biol Chem. 2003 Jun 6;278(23):20475-9. doi: 10.1074/jbc.M213159200. Epub 2003 Mar 24.
9
ATM and related protein kinases: safeguarding genome integrity.
Nat Rev Cancer. 2003 Mar;3(3):155-68. doi: 10.1038/nrc1011.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验